DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, today announces the release of its next generation Clinical Trial ...
DUBLIN--(BUSINESS WIRE)--ICON plc, (NASDAQ: ICLR) a world-leading clinical research organisation powered by healthcare intelligence, today announced the expansion of its portfolio of artificial ...
We recently compiled a list of the Top 8 Trending AI Stock Updates On Wall Street Today. In this article, we are going to take a look at where ICON Public Limited Company (NASDAQ:ICLR) stands against ...
Icon ( ($ICLR) ) has shared an announcement. On November 12, 2025, ICON plc announced that its CEO, Barry Balfe, and CFO, Nigel Clerkin, will ...
DUBLIN--(BUSINESS WIRE)-- ICON plc, (NASDAQ: ICLR) a world-leading healthcare intelligence and clinical research organisation, has been rated as one of the top-performing contract research ...
The healthcare priorities of the LGBTQ+ community have come a long way since 1973, when Charles Silverstein successfully lobbied the American Psychiatric Association to declassify homosexuality as a ...
MannKind has made the decision to discontinue the ICoN-1 Phase 3 clinical trial evaluating nebulized clofazimine inhalation ...
Findings can inform the design of context-specific recruitment strategies that reduce logistical burdens, enhance communication, and integrate cultural and community engagement. Implementing these ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback